Want to see ASTH full AI Analyst Report?
ASTH Stock Chart & Stats
$18.59
$0.06(0.19%)
At close: 4:00 PM EST
$18.59
$0.06(0.19%)
Day’s Range― - ―
52-Week Range$18.08 - $51.60
Previous CloseN/A
Volume92.25K
Average Volume (3M)702.04K
Market Cap
$2.00B
Enterprise Value$1.57K
Total Cash (Recent Filing)$478.38M
Total Debt (Recent Filing)$1.07B
Price to Earnings (P/E)65.3
Beta1.10
Next Earnings
Aug 06, 2026EPS Estimate
0.34Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.62
Shares Outstanding49,583,420
10 Day Avg. Volume526,096
30 Day Avg. Volume702,040
Financial Highlights & Ratios
PEG Ratio-1.09
Price to Book (P/B)1.56
Price to Sales (P/S)0.38
P/FCF Ratio11.65
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$48.57Price Target Upside161.28% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9
EPS Forecast (FY)1.27
Revenue Forecast (FY)$4.00B
Bulls Say, Bears Say
Bulls Say
Strong Free Cash Flow GenerationSustained, large free cash flow provides durable financial flexibility: it funds reinvestment, supports deleveraging, and reduces reliance on external financing. FCF roughly matching net income and strong growth indicate cash quality that can finance expansion and absorb near‑term volatility.
Rapid Revenue ScalingMaterial and consistent top‑line growth reflects expanding traction in value‑based care and broader payer/provider adoption. Larger revenue base enables operating leverage, supports scale economics in care management, and makes margin improvements and synergy capture more impactful over the next several quarters.
AI‑enabled Platform Driving Operational LeverageDemonstrated AI and automation metrics are structural competitive advantages: they lower costs, improve care outcomes, and accelerate provider retention. These platform efficiencies can sustainably compress G&A and medical costs over time, supporting durable margin expansion as cohorts mature and automation scales.
Bears Say
Compressed Profitability And Low ReturnsMargins and returns remain materially depressed despite revenue growth, limiting reinvestment capacity and signaling weaker unit economics at scale. Persistently low gross/net margins and modest ROE reduce resilience to adverse cost trends and make long‑term value creation contingent on sustained margin recovery.
Full‑risk Cohorts Require MaturationSignificant exposure to recently converted full‑risk populations means earnings and margin benefits are time‑phased. Until cohorts mature, medical cost volatility and below‑run‑rate profitability can persist, constraining near‑term margin expansion and creating execution risk over multiple quarters.
Enrollment And Regulatory UncertaintyDependence on public program enrollment and policy (Medicaid, ACA exchange, HQAF timing, MA risk‑adjustment rules) creates structural variability in revenue and risk pools. Conservative assumptions in guidance highlight downside exposure if enrollment or payment frameworks shift, affecting multi‑period cash flow visibility.
ASTH FAQ
What was Astrana Health Inc.’s price range in the past 12 months?
Astrana Health Inc. lowest stock price was $18.08 and its highest was $51.60 in the past 12 months.
What is Astrana Health Inc.’s market cap?
Astrana Health Inc.’s market cap is $2.00B.
When is Astrana Health Inc.’s upcoming earnings report date?
Astrana Health Inc.’s upcoming earnings report date is Aug 06, 2026 which is in 11 days.
How were Astrana Health Inc.’s earnings last quarter?
Astrana Health Inc. released its earnings results on May 07, 2026. The company reported $0.29 earnings per share for the quarter, missing the consensus estimate of $0.299 by -$0.009.
Is Astrana Health Inc. overvalued?
According to Wall Street analysts Astrana Health Inc.’s price is currently Undervalued.
Does Astrana Health Inc. pay dividends?
Astrana Health Inc. does not currently pay dividends.
What is Astrana Health Inc.’s EPS estimate?
Astrana Health Inc.’s EPS estimate is 0.34.
How many shares outstanding does Astrana Health Inc. have?
Astrana Health Inc. has 49,583,420 shares outstanding.
What happened to Astrana Health Inc.’s price movement after its last earnings report?
Astrana Health Inc. reported an EPS of $0.29 in its last earnings report, missing expectations of $0.299. Following the earnings report the stock price went up 8.925%.
Which hedge fund is a major shareholder of Astrana Health Inc.?
Currently, no hedge funds are holding shares in ASTH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Astrana Health Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$48.57 (161.28% Upside)
$48.57 (161.28% Upside)
Blogger Sentiment
Bullish
ASTH Sentiment 70%
Sector Average 65%
Sector Average 65%
Hedge Fund Trend
Increased
By 224.5K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 8.7%
Last 30 Days ▲ 25.5%
Last 30 Days ▲ 25.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
82.66%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
77.19%
Trailing 12-Months
Company Description
Astrana Health Inc.
Astrana Health, Inc., which rebranded from Apollo Medical Holdings, Inc. in February 2024, is a healthcare management firm based in Alhambra, California, founded in 1985. This company delivers medical services throughout the United States, operating with a physician-centered approach powered by advanced technology. Its operations are structured across three distinct divisions: Care Partners, Care Delivery, and Care Enablement. Astrana Health utilizes its exclusive platform for population health management and healthcare delivery to implement an integrated, value-based care model. This strategic approach empowers the healthcare providers within its network to offer high-quality care to their patients. The organization provides extensive care coordination services to a broad spectrum of stakeholders, including patients, their families, primary care physicians, specialists, acute care hospitals, other inpatient facilities, physician groups, and health plans. Its robust physician network encompasses primary care doctors, specialized practitioners, advanced practice providers (extenders), and hospital-based physicians. Astrana Health serves a diverse patient base, primarily those with insurance coverage—such as private plans, Medicare, Medicaid, and HMOs—but also extends care to uninsured individuals.
ASTH Stock 12 Month Forecast
Average Price Target
$48.57
▲(161.28% Upside)
Technical Analysis
Healthcare Services
―
Pediatrix Medical Group
―
―
US Physical Therapy
―
Aveanna Healthcare Holdings
―
Ownership Overview
36.16% Insiders
16.58% Mutual Funds
0.55% Other Institutional Investors
22.02% Public Companies and
Individual Investors









